Reuters -- An experimental anti-inflammatory drug being developed by Celgene Corp. met the primary goal of a mid-stage study of patients with psoriatic arthritis, according to preliminary results announced by the biotechnology company on Monday.
Reuters -- An experimental anti-inflammatory drug being developed by Celgene Corp. met the primary goal of a mid-stage study of patients with psoriatic arthritis, according to preliminary results announced by the biotechnology company on Monday.
